Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations

The high prices of innovative medicines endanger access to care worldwide. Sustainable prices need to be affordable while sufficiently incentivizing research and development (R&D) investments. A proposed solution is increased transparency. Proponents argue that price and R&D cost confidentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzen, Nora, Ziegler, Andreas, Romagnoli, Giorgia, Retèl, Valesca P., Offerman, Theo J.S., van Harten, Wim H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973423/
https://www.ncbi.nlm.nih.gov/pubmed/36860697
http://dx.doi.org/10.1158/2767-9764.CRC-21-0031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973423/
https://www.ncbi.nlm.nih.gov/pubmed/36860697
http://dx.doi.org/10.1158/2767-9764.CRC-21-0031

Ejemplares similares